General technical requirements for production and quality control of human gene therapy productsLI Yong-hong, BI Hua, SHI Xin-chang, QIN Xi, RAO Chun-ming2482-2489
Establishment of reference materials for in vitro diagnostics of lung cancer relevant mutations based on next-generation sequencingLIU Dong-lai, ZHANG Xin-yuan, ZHOU Hai-wei, SHEN Shu, WANG Hai-bo, ZHANG Chun-tao2490-2497
Development of a novel process for purification of acellular component pertussis vaccineHU Ye-qin, DUAN Kai, LI Xin-guo, PAN Cong, TIAN Cong, TANG Rong-xing, ZHU De-wu, QU Ming-xia, YANG Xiao-ming2498-2504
Challenges and suggestions on the implementation of Marketing Authorization Holder for blood products in ChinaDAI Wei, WANG Xue-wei, YANG Lu-yao, SHI Nan, YANG Yue2505-2510
Quality evaluation for biological effectiveness of human mesenchymal stem cellsHAN Xiao-yan, NA Tao, ZHANG Ke-hua, YUAN Bao-zhu2511-2518
Method validation of CHO host cell residual DNA quantitative kit (PCR-Taqman probe)L(U) Ping, YANG Zhi-xing, ZHANG Hui, ZONG Wei-ying, WU Wan-xin, WANG Tao, LIANG Cheng-gang2519-2526
Progress in clinical research of prophylactic human papillomavirus vaccineYU Bang-wei, LI Ke, ZHOU Chen-liang, CHEN Zhu2527-2533
Advance in pharmacokinetic studies of antisense oligonucleotidesFU Jie, WANG Hai-xue, SONG Hai-feng2534-2543